Long-term Follow up Local Registry Study of Kymriah in South Korea

Clinical trial NCT06785818 · RECRUITING

Trial details

NCT number: NCT06785818
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma

Start date: 2025-03-12
Primary completion: 2039-12-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.